{"schema_version":"1","generated_at":"2026-11-09T19:20:21.825Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/gaia-griguolo","json_url":"https://www.findmykol.com/kol/gaia-griguolo/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"gaia-griguolo","name":"Gaia Griguolo","credential":"MD","title":"Medical oncologist, Veneto Institute of Oncology (IOV IRCCS), Padua","specialty":"Medicine","therapeutic_area":"Breast","therapeutic_areas":["Breast","Gastrointestinal"],"institution":"University of Padua","institution_url":"https://www.findmykol.com/institution/university-of-padua","register":{"country":"IT"}},"identifiers":{"orcid":"0000-0002-8782-4509","openalex":"A5085165482"},"summary":"Gaia Griguolo is Medical oncologist, Veneto Institute of Oncology (IOV IRCCS), Padua at University of Padua. OpenAlex indexes 218 publications with 3,728 citations (h-index 35).","overview":{"text":"Gaia Griguolo is Medical oncologist, Veneto Institute of Oncology (IOV IRCCS), Padua at University of Padua, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG). The public record shows 218 publications with 3,728 citations (h-index 35), centered on Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Gastric Cancer Management and Outcomes.","bullets":["Most recent indexed publication: 2026 · Cancer discovery","Top research focus: Breast Cancer Treatment Studies"],"generated_at":"2026-11-09"},"focus":{"indications":[{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"IBS / Functional GI","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Breast Cancer Treatment Studies","HER2/EGFR in Cancer Research","Gastric Cancer Management and Outcomes","Breast Lesions and Carcinomas","Advanced Breast Cancer Therapies"]},"scholarship":{"works_count":218,"cited_by_count":3728,"h_index":35,"i10_index":68,"pubmed_count":30,"latest_activity_year":2026,"source":"works"},"trials":{"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":58,"years":{"first":2014,"last":2026},"societies":["AACR","ASCO","ESMO"],"shown":3,"withheld":55,"rows":[{"title":"Abstract 7907: Genomic, immune, and clinical characterization of estrogen receptor-positive, HER2-low breast cancer: The NextGIM trial latest updates","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-7907","source_url":"https://doi.org/10.1158/1538-7445.am2026-7907","status":"verified"},{"title":"Genomic and clinical characterization of estrogen receptor–positive/HER2-negative early breast cancer: Results from the NextGIM study.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e12590","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e12590","status":"verified"},{"title":"Spatial interactions between immune cells as a predictor of pCR to neoadjuvant chemotherapy (NACT) and nivolumab for ER+/HER2− breast cancer (BC): Analysis of the phase II GIADA trial.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.567","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.567","status":"verified"}],"source":"congress"},"publications":{"total":30,"shown":5,"withheld":25,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Extracellular matrix stiffness controls Transposable Elements through Pin1 to promote immune evasion in breast cancer.","year":2026,"journal":"Cancer discovery","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42949540/","status":"verified"},{"title":"Proactive Brain Screening Using Contrast-Enhanced Brain CT Scans in HER2+ Metastatic Breast Cancer.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41661219/","status":"verified"},{"title":"Long-term outcome of isolated locoregional breast cancer recurrence: a large retrospective mono-institutional study.","year":2026,"journal":"The oncologist","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42011506/","status":"verified"},{"title":"Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.","year":2025,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40905841/","status":"verified"},{"title":"Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab.","year":2025,"journal":"NPJ breast cancer","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41298527/","status":"verified"}],"source":"publications"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"Medical degree (MD), University of Padua","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"},{"value":"Specialization in medical oncology, University of Padua","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"}]},"roles":{"total":3,"shown":3,"rows":[{"value":"Member, American Society of Clinical Oncology (ASCO)","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"},{"value":"Member, European Society for Medical Oncology (ESMO)","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"},{"value":"Member, Italian Association of Medical Oncology (AIOM)","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"Young Investigator Award in Breast Cancer, Conquer Cancer Foundation (2019)","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"},{"value":"ESMO Merit Award, ESMO Breast Cancer 2019","source_url":"https://www.ioveneto.it/wp-content/uploads/2019/03/CV_Griguolo_ITA.pdf","status":"provisional","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Veneto Institute of Oncology (IOV IRCCS), Padua, Department of Medical Oncology","source_url":"https://www.vjoncology.com/speaker/gaia-griguolo/","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Cristina Basso","slug":"cristina-basso","institution":"University of Padua","url":"https://www.findmykol.com/kol/cristina-basso","json_url":"https://www.findmykol.com/kol/cristina-basso/profile.json"},{"name":"Amelia Ruffatti","slug":"amelia-ruffatti","institution":"University of Padua","url":"https://www.findmykol.com/kol/amelia-ruffatti","json_url":"https://www.findmykol.com/kol/amelia-ruffatti/profile.json"},{"name":"Claudio Ronco","slug":"claudio-ronco","institution":"University of Padua","url":"https://www.findmykol.com/kol/claudio-ronco","json_url":"https://www.findmykol.com/kol/claudio-ronco/profile.json"},{"name":"Gaetano Thiene","slug":"gaetano-thiene","institution":"University of Padua","url":"https://www.findmykol.com/kol/gaetano-thiene","json_url":"https://www.findmykol.com/kol/gaetano-thiene/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Hope Rugo","slug":"hope-rugo","institution":"City of Hope","specialty":"Hematology","url":"https://www.findmykol.com/kol/hope-rugo","json_url":"https://www.findmykol.com/kol/hope-rugo/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":55,"publications":25}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}